Literature DB >> 32506469

Genetic Determinants of Cirrhosis and Hepatocellular Carcinoma Due to Fatty Liver Disease: What's the Score?

Ruth M Pfeiffer1, Yaron Rotman2, Thomas R O'Brien1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32506469      PMCID： PMC8900528          DOI： 10.1002/hep.31413

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.298


× No keyword cloud information.
  7 in total

1.  Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.

Authors:  Zobair M Younossi; Maria Stepanova; Mariam Afendy; Yun Fang; Youssef Younossi; Hesham Mir; Manirath Srishord
Journal:  Clin Gastroenterol Hepatol       Date:  2011-03-25       Impact factor: 11.382

Review 2.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Michael Charlton; Kenneth Cusi; Mary Rinella; Stephen A Harrison; Elizabeth M Brunt; Arun J Sanyal
Journal:  Hepatology       Date:  2017-09-29       Impact factor: 17.425

3.  Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening.

Authors:  Mitchell H Gail; Ruth M Pfeiffer
Journal:  J Natl Cancer Inst       Date:  2018-09-01       Impact factor: 13.506

4.  Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases.

Authors:  David W Crabb; Gene Y Im; Gyongyi Szabo; Jessica L Mellinger; Michael R Lucey
Journal:  Hepatology       Date:  2020-01       Impact factor: 17.425

5.  Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.

Authors:  Fasiha Kanwal; Jennifer R Kramer; Srikar Mapakshi; Yamini Natarajan; Maneerat Chayanupatkul; Peter A Richardson; Liang Li; Roxanne Desiderio; Aaron P Thrift; Steven M Asch; Jinna Chu; Hashem B El-Serag
Journal:  Gastroenterology       Date:  2018-08-23       Impact factor: 22.682

6.  Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population.

Authors:  Helene Gellert-Kristensen; Tom G Richardson; George Davey Smith; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Stefan Stender
Journal:  Hepatology       Date:  2020-09       Impact factor: 17.425

Review 7.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425
  7 in total
  3 in total

1.  Citrus maxima and tea regulate AMPK signaling pathway to retard the progress of nonalcoholic fatty liver disease.

Authors:  Shuai Wen; Ran An; Zhi-Gang Li; Zhao-Xiang Lai; Dong-Li Li; Jun-Xi Cao; Ruo-Hong Chen; Wen-Ji Zhang; Qiu-Hua Li; Xing-Fei Lai; Shi-Li Sun; Ling-Li Sun
Journal:  Food Nutr Res       Date:  2022-06-10       Impact factor: 3.221

Review 2.  Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications.

Authors:  Katherine Martin; Anas Hatab; Varinder S Athwal; Elliot Jokl; Karen Piper Hanley
Journal:  Curr Diab Rep       Date:  2021-02-05       Impact factor: 4.810

3.  Editorial: Insights in gastroenterology: 2021.

Authors:  Angel Lanas; Guillermo García-Rayado
Journal:  Front Med (Lausanne)       Date:  2022-09-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.